top of page

DONNÉES CLINIQUES
HELIOSPHERE

Une publication récente sur l’expérience brésilienne avec plus de 40 000 ballons posés permet une vision consensuelle de l’état de l’art du traitement du surpoids et de l’obésité par ballon intragastrique (BIG). Selon ce collège d’expert, le ballon a un large éventail d'indications, des patients en surpoids (indice de masse corporelle [IMC] ≥27 kg/m2), aux obèses qui ne répondent pas aux critères de la chirurgie bariatrique, et aux super-obèses (IMC ≥50 kg/m2), comme passerelle vers la chirurgie bariatrique. HELIOSPHERE répond à ces indications.

Capture d’écran 2023-02-21 à 20.39.06.png
Capture d’écran 2023-02-21 à 20.42.24.png

RÉFÉRENCES

1 Rizwan (2022), Retrospective study of efficacy and tolerance of 6 months treatment by Intragastric Balloon Heliosphere® Newtech (on going)

2 Goyal, H., et al. (2021). Endobariatric procedures for obesity: clinical indications and available options. Therapeutic Advances in Gastrointestinal Endoscopy, 14,

3 Romney (2020), Single center prospective cohort on Heliopshère Newtech (on going)

4 Gollisch, K. S. C., & Raddatz, D. (2020). Endoscopic intragastric balloon: a gimmick or a viable option for obesity?. Annals of translational medicine, 8(Suppl 1).

5 Espinet-Coll, E. (2017) "Multicenter study on the safety of bariatric endoscopy." Rev Esp Enferm Dig 109(5): 350-357.

6 Rizwan (2017), Intragastric balloon is still an option, but what about its efficacy. Our experience in Doha-Qatar (Poster at the 22nd World Congress Of IFSO, London, England)

7 Coenye (2017), Single center prospective cohort on Heliopshère Newtech (CREGG 2017)

8 Erdem, H., et al. (2016). "Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study." Dicle Tıp Dergisi 43(1).

9 Palmisano, S., et al. (2016). "Intragastric Balloon Device: Weight Loss and Satisfaction Degree." Obesity surgery 26(9): 2131-2137.

10 Houissa, F., et al. (2014). Efficiency of endoscopic treatment with intra gastric balloon in severe to morbid obesity. La Tunisie medicale, 92(12), 717-722.

11  Masini, A. (2014). Role Of The Air-Blown Intragastric Balloon (Heliosphere®) As A Preoperative Treatment In Super-Obese Subjects: Retrospective Analysis On 85 Cases. (Poster at XXII Congresso Nazionale SICOB 2014)

12 Kolesnikov (2013). Air- and Liquid-filled intragastric balloons in treatment of obese and super obese patients (Poster at the 18nd World Congress Of IFSO, Istanbul, Turkey)

bottom of page